Clinical Trials
70 trialsIACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
Trop2-targeted immunoPET Imaging of Solid Tumors
RenJi Hospital
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
M.D. Anderson Cancer Center
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Peking University First Hospital
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Cancer Research UK
iCaRe2
University of Nebraska
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
University of California, Irvine
DETERMINE
Cancer Research UK
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Kaiser Permanente
ONE TEAM
Duke University
SCANDARE
Institut Curie
DETERMINE
Cancer Research UK
LIBERATE
University Health Network, Toronto
DETERMINE
Cancer Research UK
IMPROVE
Memorial Sloan Kettering Cancer Center
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Maastricht University Medical Center
DECIDE
Institut Claudius Regaud
MOLTHYSO
Institut Bergonié
EARN
Washington University School of Medicine
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
CNSI-Fe(II)
Sichuan Enray Pharmaceutical Sciences Company
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
University of California, Irvine
AMPLIFY
University of Alabama at Birmingham
MOHCCN-O
University Health Network, Toronto
Proteomic Analysis of Patients Undergoing Bariatric Surgery
Universidade Federal de Pernambuco
Dragon
Washington University School of Medicine
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
Zhejiang University
Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer
Comprehensive Support Project for Oncology Research
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
CAPABLE-IT
Istituti Clinici Scientifici Maugeri SpA
AcSé
UNICANCER
OPTI-DOSE
University Medical Center Groningen
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
Emory University
Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors
Herlev Hospital
GASVERT
Institut de Cancérologie de Lorraine
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Ludwig Institute for Cancer Research
WiZen
Technische Universität Dresden
MICROBIOME
Imperial College London
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Roswell Park Cancer Institute
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Weill Medical College of Cornell University
YSCH-01
Shanghai Fengxian District Central Hospital
ONCOPRO
Hospices Civils de Lyon
Investigator Initiated Phase 1 Study of TBI-1201
Mie University
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors
Zhujiang Hospital
IOSI-NDU-001
Oncology Institute of Southern Switzerland
N1
CureOne
Investigator Initiated Phase 1 Study of TBI-1301
Mie University